About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 627182, 10 pages
http://dx.doi.org/10.1155/2013/627182
Review Article

A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency

Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 22 July 2012; Accepted 11 December 2012

Academic Editor: Yoshiyuki Kimura

Copyright © 2013 Nyuk Jet Chong and Zoriah Aziz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. N. Nicolaides, “Investigation of chronic venous insufficiency: a consensus statement (France, March 5–9, 1997),” Circulation, vol. 102, no. 20, pp. E126–E163, 2000. View at Scopus
  2. X. Kurz, S. R. Kahn, L. Abenhaim et al., “Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous insufficiency epidemiologic and economic studies,” International Angiology, vol. 18, no. 2, pp. 83–102, 1999. View at Scopus
  3. R. M. Kaplan, M. H. Criqui, J. O. Denenberg, J. Bergan, and A. Fronek, “Quality of life in patients with chronic venous disease: San Diego population study,” Journal of Vascular Surgery, vol. 37, no. 5, pp. 1047–1053, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Virgini-Magalhães, C. L. Porto, F. F. A. Fernandes, D. M. Dorigo, D. A. Bottino, and E. Bouskela, “Use of microcirculatory parameters to evaluate chronic venous insufficiency,” Journal of Vascular Surgery, vol. 43, no. 5, pp. 1037–1044, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Criqui, M. Jamosmos, A. Fronek et al., “Chronic venous disease in an ethnically diverse population: the San Diego population study,” American Journal of Epidemiology, vol. 158, no. 5, pp. 448–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Lévy, F. Los, H. Chevalier, and P. Lévy, “The 1999 French venous disease survey: epidemiology, management, and patient profiles,” Angiology, vol. 52, no. 3, pp. 195–199, 2001. View at Scopus
  7. J. L. Beebe-Dimmer, J. R. Pfeifer, J. S. Engle, and D. Schottenfeld, “The epidemiology of chronic venous insufficiency and varicose veins,” Annals of Epidemiology, vol. 15, no. 3, pp. 175–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Švestková and A. Pospíšilová, “Risk factors of chronic venous disease inception,” Scripta Medica, vol. 81, no. 2, pp. 117–128, 2008. View at Scopus
  9. P. J. Pappas, W. N. Durán, and R. W. Hobson, “Pathology and cellular physiology of chronic venous insufficiency,” in Handbook of Venous Disorders, P. Gloviczki and J. Yao, Eds., pp. 58–67, Hodder Arnold, New York, NY, USA, 2001.
  10. M. T. De Sanctis, L. Incandela, G. Belcaro, and M. R. Cesarone, “Topical treatment of venous microangiopathy in patients with venous ulceration with Essaven gel: a placebo-controlled, randomized study,” Angiology, vol. 52, no. 3, pp. S29–S34, 2001. View at Scopus
  11. M. T. De Sanctis, M. R. Cesarone, L. Incandela, G. Belcaro, and G. Acerbi, “Methods of evaluation and quantification of microangiopathy in high perfusion microangiopathy (chronic venous insufficiency and diabetic microangiopathy),” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 7, no. 1, pp. S3–S6, 2002. View at Scopus
  12. M. Rosaria Cesarone, G. Belcaro, S. Errichi et al., “Microcirculatory effects of Viatromb spray gel heparin in chronic venous insufficiency: evaluation of TcPO2 and PCO2—a product evaluation study,” Angiology, vol. 58, no. 1, supplement, pp. 21S–26S, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Kecelj Leskovec, M. D. Pavlović, and T. Lunder, “A short review of diagnosis and compression therapy of chronic venous insufficiency,” Acta Dermatovenerologica Alpina, Pannonica et Adriatica, vol. 17, no. 1, pp. 17–21, 2008. View at Scopus
  14. A. C. W. Ting, S. W. K. Cheng, P. Ho, J. T. C. Poon, L. L. H. Wu, and G. C. Y. Cheung, “Surgical treatment for advanced chronic venous insufficiency in Hong Kong,” Annals of the College of Surgeons of Hong Kong, vol. 8, no. 4, pp. 135–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Raju, K. Hollis, and P. Neglen, “Use of compression stockings in chronic venous disease: patient compliance and efficacy,” Annals of Vascular Surgery, vol. 21, no. 6, pp. 790–795, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Lazzarini and L. Danieli, “Clinical controlled trial of aminaphtone in lower limbs' phlebopathies and phlebopathic ulcers,” Rassegna Internazionale di Clinica e Terapia, vol. 62, no. 12, pp. 825–844, 1982. View at Scopus
  17. F. Flota-Cervera, C. Flota-Ruiz, C. Treviño, and A. Berber, “Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease,” Angiology, vol. 59, no. 3, pp. 352–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Gohel and A. H. Davies, “Pharmacological agents in the treatment of venous disease: an update of the available evidence,” Current Vascular Pharmacology, vol. 7, no. 3, pp. 303–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ciapponi, E. Laffaire, and M. Roqué, “Calcium dobesilate for chronic venous insufficiency: a systematic review,” Angiology, vol. 55, no. 2, pp. 147–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Martinez, X. Bonfill, R. M. Moreno, E. Vargas, and D. Capellà, “Phlebotonics for venous insufficiency,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003229, 2005. View at Scopus
  21. M. J. Martínez-Zapata, R. M. Moreno, I. Gich, G. Urrútia, X. Bonfill, and Chronic Venous Insufficiency Study Group, “A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease,” European Journal of Vascular and Endovascular Surgery, vol. 35, no. 3, pp. 358–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. A. Lyseng-Williamson and C. M. Perry, “Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids,” Drugs, vol. 63, no. 1, pp. 71–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Guilhou, O. Dereure, L. Marzin et al., “Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients,” Angiology, vol. 48, no. 1, pp. 77–85, 1997. View at Scopus
  24. K. Katsenis, “Micronized purified flavonoid fraction (MPFF)*: a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency,” Current Vascular Pharmacology, vol. 3, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. H. Pittler and E. Ernst, “Horse chestnut seed extract for chronic venous insufficiency,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003230, 2006. View at Scopus
  26. L. Pascarella, “Essentials of Daflon 500 mg: from early valve protection to long-term benefits in the management of chronic venous disease,” Current Pharmaceutical Design, vol. 13, no. 4, pp. 431–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. N. Nicolaides, “From symptoms to leg edema: efficacy of Daflon 500 mg,” Angiology, vol. 54, supplement 1, pp. S33–S44, 2003. View at Scopus
  28. L. Bevege, “Centella asiatica: a review,” Australian Journal of Medical Herbalism, vol. 16, no. 1, pp. 15–27, 2004.
  29. B. Brinkhaus, M. Lindner, D. Schuppan, and E. G. Hahn, “Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica,” Phytomedicine, vol. 7, no. 5, pp. 427–448, 2000. View at Scopus
  30. M. Liu, Y. Dai, X. Yao et al., “Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice,” International Immunopharmacology, vol. 8, no. 11, pp. 1561–1566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Kedzia, T. Bobkiewicz-Kozlowska, M. Furmanowa, et al., “Studies on the biological properties of extracts from Centella asiatica (L.) Urban herb,” Herba Polonica, vol. 53, no. 1, pp. 34–44, 2007.
  32. Y. Kimura, M. Sumiyoshi, K. I. Samukawa, N. Satake, and M. Sakanaka, “Facilitating action of asiaticoside at low doses on burn wound repair and its mechanism,” European Journal of Pharmacology, vol. 584, no. 2-3, pp. 415–423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Incandela, M. R. Cesarone, M. Cacchio et al., “Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy,” Angiology, vol. 52, supplement 2, pp. S9–S13, 2001. View at Scopus
  34. D. V. C. Awang, “Gotu kola,” Canadian Pharmaceutical Journal, vol. 131, no. 7, pp. 42–46, 1998. View at Scopus
  35. H. Wohlmuth, “Gotu kola,” Botany Pathways, vol. 7, pp. 7–8, 1999.
  36. D. Arora, M. Kumar, and S. D. Dubey, “Centella asiatica—a review of its medicinal uses and pharmacological effects,” Journal of Natural Remedies, vol. 2, no. 2, pp. 143–149, 2002. View at Scopus
  37. A. P. K. Ling and S. Hussein, “A summary report on chemical constituents and medicinal uses of Centella asiatica,” Journal of Tropical Medicinal Plants, vol. 8, no. 1, pp. 111–119, 2007.
  38. C. Allegra, G. Pollari, A. Criscuolo, M. Bonifacio, and D. Tabassi, “Centella asiatica extract in venous disorders of the lower limbs. Comparative clinical and instrumental trial against a placebo,” La Clinica Terapeutica, vol. 99, no. 5, pp. 507–513, 1981. View at Scopus
  39. F. Marastoni, A. Baldo, G. Redaelli, and L. Ghiringhelli, “Centella asiatica extract in venous diseases of the lower limbs and a comparison between its effectiveness and that of tribenoside,” Minerva Cardioangiologica, vol. 30, no. 4, pp. 201–207, 1982. View at Scopus
  40. J. P. Pointel, H. Boccalon, M. Cloarec, C. Ledevehat, and M. Joubert, “Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs,” Angiology, vol. 38, no. 1, pp. 46–50, 1987. View at Scopus
  41. M. R. Cesarone, G. Laurora, M. T. De Sanctis et al., “The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study,” Minerva Cardioangiologica, vol. 42, no. 6, pp. 299–304, 1994. View at Scopus
  42. M. R. Cesarone, G. Belcaro, M. T. De Sanctis et al., “Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial,” Angiology, vol. 52, supplement 2, pp. S15–S18, 2001. View at Scopus
  43. M. R. Cesarone, G. Belcaro, A. Rulo et al., “Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry,” Angiology, vol. 52, supplement 2, pp. S45–S48, 2001. View at Scopus
  44. M. T. De Sanctis, G. Belcaro, L. Incandela et al., “Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial,” Angiology, vol. 52, supplement 2, pp. S55–S59, 2001. View at Scopus
  45. L. Incandela, G. Belcaro, M. T. De Sanctis et al., “Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model,” Angiology, vol. 52, supplement 2, pp. S61–S67, 2001. View at Scopus
  46. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, 2009, http://handbook.cochrane.org/.
  47. M. R. Cesarone, L. Incandela, M. T. De Sanctis et al., “Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model,” Angiology, vol. 52, supplement 2, pp. S49–S54, 2001. View at Scopus
  48. L. Incandela, G. Belcaro, M. R. Cesarone et al., “Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study,” Angiology, vol. 52, supplement 2, pp. S27–S31, 2001. View at Scopus
  49. M. Cospite, F. Ferrara, G. Milio, and F. Meli, “Study about pharmacologic and clinical activity of Centella asiatica titrated extract in the cronic venous deficiency of the lower limbs: valuation with strain gauge plethismography,” Giornale Italiano di Angiologia, vol. 4, no. 3, pp. 200–205, 1984. View at Scopus
  50. M. R. Cesarone, L. Incandela, M. T. De Sanctis et al., “Flight microangiopathy in medium-to long-distance flights: prevention of edema and microcirculation alterations with total triterpenic fraction of Centella asiatica,” Angiology, vol. 52, supplement 2, pp. S33–S37, 2001. View at Scopus
  51. G. V. Belcaro, R. Grimaldi, and G. Guidi, “Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA,” Angiology, vol. 41, no. 7, pp. 533–540, 1990. View at Scopus
  52. M. R. Cesarone, G. Laurora, M. T. De Sanctis, and G. Belcaro, “Activity of Centella asiatica in venous insufficiency,” Minerva Cardioangiologica, vol. 40, no. 4, pp. 137–143, 1992. View at Scopus
  53. P. R. Williamson, C. Gamble, D. G. Altman, and J. L. Hutton, “Outcome selection bias in meta-analysis,” Statistical Methods in Medical Research, vol. 14, no. 5, pp. 515–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Allegra, “Comparative capillaroscopic study of certain bioflavonoids and total triterpenic fractions of Centella asiatica in venous insufficiency,” La Clinica Terapeutica, vol. 110, no. 6, pp. 555–559, 1984. View at Scopus
  55. M. D. Flather, M. E. Farkouh, J. M. Pogue, and S. Yusuf, “Strengths and limitations of meta-analysis: larger studies may be more reliable,” Controlled Clinical Trials, vol. 18, no. 6, pp. 568–579, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Walker, A. V. Hernandez, and M. W. Kattan, “Meta-analysis: its strengths and limitations,” Cleveland Clinic Journal of Medicine, vol. 75, no. 6, pp. 431–439, 2008. View at Scopus
  57. M. Zwahlen, A. Renehan, and M. Egger, “Meta-analysis in medical research: potentials and limitations,” Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 3, pp. 320–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Pigott, “Handling missing data in research synthesis,” in The Handbook of Research Synthesis, H. Cooper and L. Hedges, Eds., pp. 163–175, Russell Sage Foundation, New York, NY, USA, 1994.
  59. G. Lewis, R. Churchill, and M. Hotopp, “Editorial: systematic reviews and meta-analysis,” Psychological Medicine, vol. 27, no. 1, pp. 3–7, 1997. View at Scopus
  60. K. F. Schulz and D. A. Grimes, “Blinding in randomised trials: hiding who got what,” Lancet, vol. 359, no. 9307, pp. 696–700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Belcaro, D. Christopoulos, and A. N. Nicolaides, “Skin flow and swelling in post-phlebitic limbs,” Vasa, vol. 18, no. 2, pp. 136–139, 1989. View at Scopus
  62. G. Laurora, M. R. Cesarone, L. Incandela, and G. Belcaro, “Skin blood flux and the venoarteriolar response in the perimalleolar area in patients with venous hypertension,” Panminerva Medica, vol. 34, no. 3, pp. 115–119, 1992. View at Scopus
  63. L. Wood, M. Egger, L. L. Gluud et al., “Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study,” British Medical Journal, vol. 336, no. 7644, pp. 601–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials,” British Medical Journal, vol. 340, no. 7748, pp. 698–702, 2010. View at Publisher · View at Google Scholar · View at Scopus